Sun Pharma introduces a novel class of drug, Fexuclue®(Fexuprazan) in India for treatment of Erosive Esophagitis
פוסטים אחרונים
- Sun Pharma signs Definitive Agreement to Acquire Organon
- Sun Pharma launches its semaglutide injection under the brand names, Noveltreat and Sematrinity in India
- Sun Pharma Announces US FDA Acceptance of Supplemental Biologics License (sBLA) Application for ILUMYA® (tildrakizumab-asmn) for the Treatment of Adults with Active Psoriatic Arthritis
- Sun Pharma Comes on Board as Principal Sponsor and Health Partner of Royal Challengers Bengaluru (RCB) for T20 Season 2026
- Sun Pharma reports Q3FY26 results
תגובות אחרונות